Macrolides in the Respiratory Tract in Cystic Fibrosis

Overview

Journal J R Soc Med

Specialty General Medicine

Date 2002 Sep 10

PMID 12216272

Citations 2

Authors

Adam Jaffe

Mark Rosenthal

Affiliations

Soon will be listed here.

Citing Articles

Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis.

Beringer P, Huynh K, Kriengkauykiat J, Bi L, Hoem N, Louie S Antimicrob Agents Chemother. 2005; 49(12):5013-7.

PMID: 16304166 PMC: 1315964. DOI: 10.1128/AAC.49.12.5013-5017.2005.

New therapeutic approaches for cystic fibrosis lung disease.

Davies J J R Soc Med. 2002; 95 Suppl 41:58-67.

PMID: 12216276 PMC: 1308638.

References

Hand W, Hand D . Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1990; 34(5):863-70. PMC: 171707. DOI: 10.1128/AAC.34.5.863. View

Anderson R . Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation. J Infect Dis. 1989; 159(5):966-73. DOI: 10.1093/infdis/159.5.966. View

Yamasaki T . [Adherence of Pseudomonas aeruginosa to mouse tracheal epithelium--the effect of antimicrobial agents]. Kansenshogaku Zasshi. 1990; 64(5):575-83. DOI: 10.11150/kansenshogakuzasshi1970.64.575. View

Hoiby N, Koch C . Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management. Thorax. 1990; 45(11):881-4. PMC: 462789. DOI: 10.1136/thx.45.11.881. View

Dupont M, Lapointe J . Quantitative effect of roxithromycin and rifampicin on mucoid cultures from directly plated sputum of cystic fibrosis patients chronically colonized with Pseudomonas aeruginosa. Drugs Exp Clin Res. 1990; 16(12):597-605. View

Nagai H, Shishido H, Yoneda R, Yamaguchi E, Tamura A, Kurashima A . Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration. 1991; 58(3-4):145-9. DOI: 10.1159/000195915. View

Torre D, Broggini M, Botta V, Sampietro C, Busarello R, Garberi C . In vitro and ex vivo effects of recent and new macrolide antibiotics on chemotaxis of human polymorphonuclear leukocytes. J Chemother. 1991; 3(4):236-9. DOI: 10.1080/1120009x.1991.11739097. View

Tamaoki J, Isono K, Sakai N, Kanemura T, Konno K . Erythromycin inhibits Cl secretion across canine tracheal epithelial cells. Eur Respir J. 1992; 5(2):234-8. View

Ichikawa Y, Ninomiya H, Koga H, Tanaka M, Kinoshita M, Tokunaga N . Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis. 1992; 146(1):196-203. DOI: 10.1164/ajrccm/146.1.196. View

10.

AKAI S, Okayama H, Shimura S, Tanno Y, Sasaki H, Takishima T . Delta F508 mutation of cystic fibrosis gene is not found in chronic bronchitis with severe obstruction in Japan. Am Rev Respir Dis. 1992; 146(3):781-3. DOI: 10.1164/ajrccm/146.3.781. View

11.

Kadota J, Sakito O, Kohno S, Sawa H, Mukae H, Oda H . A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis. 1993; 147(1):153-9. DOI: 10.1164/ajrccm/147.1.153. View

12.

Tredaniel J, Zalcman G, Gerber F, DAgay M, Capron F, Frija J . Diffuse panbronchiolitis: efficacy of low-dose erythromycin. Respir Med. 1993; 87(3):229-30. DOI: 10.1016/0954-6111(93)90099-l. View

13.

Nakashio S, Susa C, Qiu S, Kijima A, Iwasawa H, Shimomura H . [Antimicrobial activity of clarithromycin and its effect on bacterial adherence to medical material]. Jpn J Antibiot. 1993; 46(6):428-36. View

14.

Hoiby N . Diffuse panbronchiolitis and cystic fibrosis: East meets West. Thorax. 1994; 49(6):531-2. PMC: 474936. DOI: 10.1136/thx.49.6.531. View

15.

Koyama H, Nishimura K, Mio T, Ikeda A, Sugiura N, Izumi T . Bronchial responsiveness and acute bronchodilator response in chronic obstructive pulmonary disease and diffuse panbronchiolitis. Thorax. 1994; 49(6):540-4. PMC: 474939. DOI: 10.1136/thx.49.6.540. View

16.

Oda H, Kadota J, Kohno S, Hara K . Erythromycin inhibits neutrophil chemotaxis in bronchoalveoli of diffuse panbronchiolitis. Chest. 1994; 106(4):1116-23. DOI: 10.1378/chest.106.4.1116. View

17.

Khan T, Wagener J, Bost T, Martinez J, Accurso F, Riches D . Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995; 151(4):1075-82. DOI: 10.1164/ajrccm/151.4.1075. View

18.

Eigen H, Rosenstein B, Fitzsimmons S, Schidlow D . A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr. 1995; 126(4):515-23. DOI: 10.1016/s0022-3476(95)70343-8. View

19.

Tamaoki J, Tagaya E, Sakai A, Konno K . Effects of macrolide antibiotics on neurally mediated contraction of human isolated bronchus. J Allergy Clin Immunol. 1995; 95(4):853-9. DOI: 10.1016/s0091-6749(95)70129-x. View

20.

Aoshiba K, Nagai A, Konno K . Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrob Agents Chemother. 1995; 39(4):872-7. PMC: 162645. DOI: 10.1128/AAC.39.4.872. View